The mechanisms by which amphetamine inhibits oxidative deamination of norepinephrine in brain.
D000818:Animals; D002247:Carbon Isotopes; D002540:Cerebral Cortex / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D003042:Cocaine / Q000494:pharmacology; D003913:Dextroamphetamine / Q000494:pharmacology*; D006018:Glycols / Q000302:isolation & purification / Q000378:metabolism; D066298:In Vitro Techniques; D008333:Mandelic Acids / Q000302:isolation & purification / Q000378:metabolism; D008928:Mitochondria / Q000201:enzymology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009474:Neurons / Q000187:drug effects / Q000201:enzymology; D009638:Norepinephrine / Q000302:isolation & purification / Q000378:metabolism*; D009647:Normetanephrine / Q000302:isolation & purification; D010084:Oxidation-Reduction; D010293:Pargyline / Q000494:pharmacology; D011817:Rabbits; D013569:Synapses / Q000201:enzymology / Q000378:metabolism; D014642:Vanilmandelic Acid / Q000302:isolation & purification / Q000378:metabolism
D002247:Carbon Isotopes; D006018:Glycols; D008333:Mandelic Acids; D008996:Monoamine Oxidase Inhibitors; D009647:Normetanephrine; D014642:Vanilmandelic Acid; D010293:Pargyline; D003042:Cocaine; D003913:Dextroamphetamine; D009638:Norepinephrine